Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Opiant Pharmaceuticals Inc (OPNT)
NASDAQ:OPNT
RESEARCH TOOLSreports
Opiant Pharmaceuticals (OPNT) Financial Statements
0 Followers
Opiant Pharmaceuticals Financial Overview
| Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 0.00 | $ 2.33M | $ 2.19M | $ 13.04M | $ 14.04M |
| Gross Profit | $ 0.00 | $ 1.81M | $ 1.77M | $ 10.12M | $ 10.98M |
| EBIT | $ -9.52M | $ -11.30M | $ -11.77M | $ 1.28M | $ 3.96M |
| EBITDA | $ -9.51M | $ -11.29M | $ -11.76M | $ 1.86M | $ 3.98M |
| Net Income Common Stockholders | $ -9.92M | $ -11.74M | $ -12.19M | $ 752.33K | $ 3.42M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 35.38M | $ 40.17M | $ 50.83M | $ 52.87M | $ 50.33M |
| Total Assets | $ 41.95M | $ 48.82M | $ 60.32M | $ 70.43M | $ 68.98M |
| Total Debt | $ 16.51M | $ 14.46M | $ 14.55M | $ 17.08M | $ 19.91M |
| Net Debt | $ -18.86M | $ -25.71M | $ -36.27M | $ -35.79M | $ -30.42M |
| Total Liabilities | $ 21.45M | $ 19.23M | $ 21.06M | $ 23.59M | $ 26.97M |
| Stockholders Equity | $ 20.50M | $ 29.60M | $ 39.26M | $ 46.84M | $ 42.01M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -5.15M | $ -10.63M | $ -2.10M | $ 2.00M | $ 286.39K |
| Operating Cash Flow | $ -4.74M | $ -10.63M | $ -2.10M | $ 2.00M | $ 286.39K |
| Investing Cash Flow | $ -411.08K | $ 2.49M | $ 12.51M | $ 30.00K | $ 27.57K |
| Financing Cash Flow | $ 402.62K | $ 135.68K | $ 97.46K | $ 556.88K | $ 1.55M |
Opiant Pharmaceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.